SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,407.16 |
| Enterprise Value ($M) | 2,276.04 |
| Book Value ($M) | 531.91 |
| Book Value / Share | 8.93 |
| Price / Book | 4.53 |
| NCAV ($M) | 404.83 |
| NCAV / Share | 6.79 |
| Price / NCAV | 5.95 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.31 |
| Return on Assets (ROA) | 0.52 |
| Return on Equity (ROE) | 0.57 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.70 |
| Current Ratio | 10.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 476.77 |
| Assets | 603.86 |
| Liabilities | 71.94 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Biotechnology Value Fund L P | 4.90 | -48.47 | |
| 13G/A | Vanguard Group Inc | 7.15 | 0.00 | |
| 13G | State Street Corp | 5.40 | 16.62 | |
| 13G/A | BlackRock, Inc. | 18.20 | 92.35 | |
| 13G/A | Point72 Asset Management, L.P. | 4.50 | -17.97 | |
| 13G/A | Citadel Advisors Llc | 0.70 | ||
| 13G/A | Rtw Investments, Lp | 9.20 | 47.98 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 2.24 | -56.29 | |
| 13G/A | Farallon Capital Partners, L.P. | 9.99 | 14.05 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 557,139 | 2,763,474 | 20.16 | |
| 95,297 | 386,285 | 24.67 | |
| 209,795 | 919,120 | 22.83 | |
| 68,691 | 513,851 | 13.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OMER – Omeros Corporation | PAHC – Phibro Animal Health Corporation |
| PROC – Procaps Group S.A. | PWUP – PowerUp Acquisition Corp. |
| QTTB – Q32 Bio Inc. |
Financial data and stock pages provided by
Fintel.io